Search
Incannex Healthcare Inc
IXHLAdd to Watchlist
3.180USD
-0.030-0.94%
Market hours 10/05, 10:00（ET）
38.03MMarket Cap
LossP/E TTM
Incannex Healthcare Inc (IXHL) Stock Price Target & Forecast
Analyst Rating
Based on 1 analysts giving stock ratings to Incannex Healthcare Inc in the past month.
Buy
0 Strong Buy
1 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
18.610USD+479.75%
IXHL Analyst Recommendation Trends
In the current month, IXHL has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. IXHL average Analyst price target in the last month is 18.610.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
0
0
0
0
0
0
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
0
0
0
0
IXHL Analyst Rating for Peer Comparison
Updated: Oct 4, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
13
3
0
0
26
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
IQVIA Holdings Inc
IQV
7
12
6
0
0
25
Insmed Inc
INSM
7
17
0
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Biontech SE
BNTX
4
12
6
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
Based on analysts' estimates, IXHL EPS is projected to reach -0.339 in FY2027Q1, following reported EPS of -0.203 in FY2026Q4. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
FY2027Q2
Forecast
-0.64
-0.64
-0.52
-0.34
-0.40
Actual
-0.56
-0.31
-0.20
--
--
Surprise
+13.09%
+51.18%
+60.95%
--
--
FAQs
What is Incannex Healthcare Inc's price target?
Analysts forecast that Incannex Healthcare Inc's price target is USD 18.61, with the highest forecast at USD 19.22 and the lowest forecast at USD 18.00.
How have Incannex Healthcare IncIXHL's recent earnings per share performed?
The market expectation was USD -0.20, while Incannex Healthcare IncIXHL's earnings per share (EPS) for the previous quarter was USD -0.31. EPS for the next quarter is expected at USD -0.34.
What is the analyst rating for Incannex Healthcare Inc?
Based on the ratings of Incannex Healthcare Inc's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.